Lumara Health is focused on advancing patient care. Recently acquired by AMAG Pharmaceuticals, a specialty pharmaceutical company based in Massachusetts, Lumara Health is delivering on its commitment to the women’s health community. Find out more about who we are and what we stand for.
Learn more about AMAG Pharmaceuticals.
A commitment to the fight against prematurity
In the United States, one in nine
babies is born too early (<37 weeks gestation)¹. We believe that even one baby born too early is too many. There is still work to be done to lower the number of premature births. We are dedicated to doing our part in reducing the prematurity rate through collaboration with healthcare providers to advance patient care, research and development, and collaborative community educational initiatives.
Lumara Health Sponsors 40 Weeks Documentary
Lumara Health is proud to sponsor the pregnancy documentary, 40 Weeks. Created by an award-winning documentary team, the unscripted film documents the week-by-week journey of expecting mothers and their families. The film answers pregnancy-related questions through experiences of real women and medical experts, including the importance of a full-term pregnancy. Learn more about the 40 Weeks documentary and Lumara Health’s involvement.
Making A Meaningful Difference
For Our Patients
Every week of pregnancy matters – each week the baby is reaching critical developmental milestones. Kate faced a second high risk pregnancy and the risk of delivering preterm again.
Lumara Health Announcements
AMAG Pharmaceuticals Completes Acquisition of Lumara Health’s Maternal Health Business
November 12, 2014
Lumara Health™ to Sponsor 40 Weeks Documentary to Raise Awareness of the Importance of a Full-Term Pregnancy
November 6, 2014
Lumara Health™ Announces Recipients of $75,000 in Grants to Fund Prematurity Prevention Research
October 28, 2014